Montelukast reduces seizures in pentylenetetrazol-kindled mice

AUTOR(ES)

Fleck, J., Temp, F.R., Marafiga, J.R., Jesse, A.C., Milanesi, L.H., Rambo, L.M., Mello, C.F.

FONTE

Braz J Med Biol Res

DATA DE PUBLICAÇÃO

23/02/2016

RESUMO

Cysteinyl leukotrienes (CysLTs) have been implicated in seizures and kindling; however, the effect of CysLT receptor antagonists on seizure frequency in kindled animals and changes in CysLT receptor expression after pentylenetetrazol (PTZ)-induced kindling have not been investigated. In this study, we evaluated whether the CysLT1 inverse agonist montelukast, and a classical anticonvulsant, phenobarbital, were able to reduce seizures in PTZ-kindled mice and alter CysLT receptor expression. Montelukast (10 mg/kg, sc) and phenobarbital (20 mg/kg, sc) increased the latency to generalized seizures in kindled mice. Montelukast increased CysLT1immunoreactivity only in non-kindled, PTZ-challenged mice. Interestingly, PTZ challenge decreased CysLT2 immunoreactivity only in kindled mice. CysLT1 antagonists appear to emerge as a promising adjunctive treatment for refractory seizures. Nevertheless, additional studies are necessary to evaluate the clinical implications of this research.

Documentos Relacionados

• Modulatory effects of neuropeptides on pentylenetetrazol-induced epileptic seizures and neuroinflammation in rats
• TRAXOPRODIL ATENUA AS CONVULSÕES INDUZIDAS POR PENTILENOTETRAZOL
• Quinolones potentiate cefazolin-induced seizures in DBA/2 mice.
• EFEITOS DE DIFERENTES TRATAMENTOS COM ATORVASTATINA SOBRE AS CONVULSÕES INDUZIDAS POR PENTILENOTETRAZOL
• Genetic dissection of susceptibility to audiogenic seizures in inbred mice.